Consumption of Interesterified Medium- and Long-Chain Triacylglycerols Improves Lipid Metabolism and Reduces Inflammation in High-Fat Diet-Induced Obese Rats

被引:39
作者
Du, Ying-Xue [1 ]
Chen, Sun-Ni [1 ]
Zhu, Hong-Lin [1 ]
Niu, Xian [1 ]
Li, Jing [1 ]
Fan, Ya-Wei [1 ]
Deng, Ze-Yuan [1 ]
机构
[1] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang 330047, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
medium- and long-chain triacylglycerols; anti-obesity; lipid metabolism; inflammation; STRUCTURED MEDIUM-CHAIN; GUT MICROBIOTA; BODY-FAT; INSULIN-RESISTANCE; LIVER-DISEASE; FISH-OIL; A-I; ACIDS; TRIGLYCERIDES; SERUM;
D O I
10.1021/acs.jafc.0c03103
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Medium- and long-chain triacylglycerols (MLCTs) were synthesized from rapeseed oil (RO), one kind of commonly used edible long-chain triacylglycerols (TGs), and then delivered to high-fat diet (HFD)-induced obese rats. Compared with RO, MLCT consumption exhibited more potent effects on reducing body and tissue weight gains, plasma TG, and total cholesterol (TC) levels and on improving hepatic TG, TC, fatty acid synthase, acetyl-CoA carboxylase, and lipoprteinlipase contents. Meanwhile, lower amounts of tumor necrosis factor-alpha (TNF-alpha), monocyte chemoattractant protein-1, and endotoxin in plasma, lower levels of interleukin-6 and TNF-alpha, and higher levels of interleukin-10 in both livers and white adipose tissues were detected in MLCT-fed rats. MLCT intake also remarkably suppressed the size of adipocytes and the number of macrophages. In conclusion, our study suggested that the interesterified MLCT was more efficacious in improving the lipid metabolism and inflammation in HFD-induced obese rats than RO.
引用
收藏
页码:8255 / 8262
页数:8
相关论文
共 49 条
[1]   Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance [J].
Baranova, Ancha ;
Gowder, Shobha J. ;
Schlauch, Karen ;
Elariny, Hazem ;
Collantes, Rochelle ;
Afendy, Arian ;
Ong, Janus P. ;
Goodman, Zachary ;
Chandhoke, Vikas ;
Younossi, Zobair M. .
OBESITY SURGERY, 2006, 16 (09) :1118-1125
[2]   Antibiotics protect against fructose-induced hepatic lipid accumulation in mice:: Role of endotoxin [J].
Bergheim, Ina ;
Weber, Synia ;
Vos, Miriam ;
Kraemer, Sigrid ;
Volynets, Valentina ;
Kaserouni, Seline ;
McClain, Craig J. ;
Bischoff, Stephan C. .
JOURNAL OF HEPATOLOGY, 2008, 48 (06) :983-992
[3]   Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].
Boden, G .
DIABETES, 1997, 46 (01) :3-10
[4]   Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease [J].
Boyraz, Mehmet ;
Cekmez, Ferhat ;
Karaoglu, Abdulbaki ;
Cinaz, Peyami ;
Durak, Mustafa ;
Bideci, Aysun .
BIOMARKERS IN MEDICINE, 2013, 7 (05) :737-745
[5]   High-fat diets:: Modeling the metabolic disorders of human obesity in rodents [J].
Buettner, Roland ;
Schoelmerich, Juergen ;
Bollheimer, L. Cornelius .
OBESITY, 2007, 15 (04) :798-808
[6]   Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice [J].
Cani, Patrice D. ;
Bibiloni, Rodrigo ;
Knauf, Claude ;
Neyrinck, Audrey M. ;
Neyrinck, Audrey M. ;
Delzenne, Nathalle M. ;
Burcelin, Remy .
DIABETES, 2008, 57 (06) :1470-1481
[7]   The addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice [J].
Carlson, Sarah J. ;
Nandivada, Prathima ;
Chang, Melissa I. ;
Mitchell, Paul D. ;
O'Loughlin, Alison ;
Cowan, Eileen ;
Gura, Kathleen M. ;
Nose, Vania ;
Bistrian, Bruce R. ;
Puder, Mark .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (02) :274-282
[8]   Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation [J].
de La Serre, Claire Barbier ;
Ellis, Collin L. ;
Lee, Jennifer ;
Hartman, Amber L. ;
Rutledge, John C. ;
Raybould, Helen E. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2010, 299 (02) :G440-G448
[9]   Obesity, Inflammation, and Cancer [J].
Deng, Tuo ;
Lyon, Christopher J. ;
Bergin, Stephen ;
Caligiuri, Michael A. ;
Hsueh, Willa A. .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11, 2016, 11 :421-449
[10]   Preventing the Progression of Intestinal Failure-Associated Liver Disease in Infants Using a Composite Lipid Emulsion: A Pilot Randomized Controlled Trial of SMOFlipid [J].
Diamond, Ivan R. ;
Grant, Robert C. ;
Pencharz, Paul B. ;
de Silva, Nicole ;
Feldman, Brian M. ;
Fitzgerald, Peter ;
Sigalet, David ;
Dicken, Bryan ;
Turner, Justine ;
Marchand, Valerie ;
Ling, Simon C. ;
Moore, Aideen M. ;
Avitzur, Yaron ;
Wales, Paul W. .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2017, 41 (05) :866-877